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Nasal Cellularity in 183 Unselected Schoolchildren Aged 9 to 11 Years
Roberto Ronchetti, MD*; Maria Pia Villa, MD*; Susy Martella, L Tech*; Stefania La Grutta, MD§;
Francesco Ronchetti, MD‡; Gian Luca Biscione, MD*; Jacopo Pagani, MD*; Carlo Falasca, L Tech*;
Francesco Guglielmi, L Tech*; and Mario Barreto, MD*
ABSTRACT. Objective. Although rhinitis is ex-
tremely frequent in children, methods for assessing the
severity of nasal inflammation produce results with wide
variability and hence weak clinical significance. We de-
signed this epidemiologic investigation to define the
clinical usefulness of assessing nasal cellularity in chil-
dren.
Methods. We studied 183 of 203 eligible unselected
schoolchildren who were aged 9 to 11 years and whose
parents gave informed consent and completed a ques-
tionnaire on the history of atopic and respiratory symp-
toms. In all children, nasal swabs were obtained from
both nostrils and eluted in saline and slides were pre-
pared from cytospin preparations for staining and white
cell counts. Children also underwent determination of
nasal volume, skin prick tests with 7 common local al-
lergens, flow volume curves, and nitric oxide measure-
ment in expired air. Blood samples were drawn for the
measurement of total immunoglobulin E, eosinophil per-
centage, and detection of Chlamydia pneumoniae anti-
bodies. C pneumoniae DNA was also sought in eluates
from nasal swabs. The percentage, standard deviations,
and percentiles of the various nasal white cell popula-
tions were determined.
Results. No correlation of the percentage of these
cells was found with the history of allergies or respira-
tory disease or with functional or laboratory finding.
Repeat nasal swabs obtained 1 month after the initial
examination in 31 children (20 with neutrophils higher
and 11 lower than 14%) in 77.4% of the cases confirmed
the previous (high or normal) result. Twelve of the 16
eligible children with persistently high nasal neutrophil
counts completed a 15-day cycle of intranasal flunisolide
therapy (200 g twice a day). Therapy significantly re-
duced nasal neutrophil percentage and increased nasal
volume.
Conclusions. Increased nasal neutrophils, although
related neither to the clinical history nor to laboratory
variables, are a common important finding in children.
A 15-day cycle of intranasal flunisolide is sufficient to
restore normal nasal neutrophilia. Pediatrics 2002;110:
1137–1142; nasal cellularity, neutrophils, rhinitis, allergy,
schoolchildren.
ABBREVIATIONS. NO, nitric oxide; PCR, polymerase chain reac-
tion; eNO, exhaled nitric oxide; ppb, part per billion; Ig, immu-
noglobulin; CI, confidence interval.
Rhinitis is an extremely common clinical condi-tion in children and is fundamentally sup-ported by an inflammatory state.1 The nasal
manifestations vary from a severe inflammatory
state to extremely mild or transiently asymptomatic
processes.
Over the years, numerous techniques have been
developed for objectively assessing inflammatory
problems in the nasal cavity.2,3 Despite technological
advances, no method for studying the nose and the
severity of nasal inflammation in children has been
fully standardized and widely accepted.4 A review
of the relevant literature suggests that most existing
assessment techniques have 2 basic defects: wide
variability and, hence, weak clinical significance of
the reported values.
The most direct method for studying the severity
of inflammation in the nasal mucosa is the assess-
ment of nasal cellularity, for example, by nasal wash-
ing, nasal scraping, and nasal biopsy.2,5,6 Among
these methods, nasal scraping is the most simple and
noninvasive procedure suitable for studying a large
population such as unselected schoolchildren. Few
studies have validated measurements of nasal cellu-
larity, and most results refer to preselected popula-
tion. Because few epidemiologic studies have en-
rolled unselected children, sound data on the range
of normal values and on the repeatability of results
are lacking.7 Hence, this technique still is not in
widespread clinical use.
We designed this study to provide normal values
(including mean, standard deviations, and percentile
distribution) of nasal cellularity in an unselected
population of schoolchildren who were 9 to 11 years
of age and to seek an association between nasal
cellularity and gender; questionnaire-derived clinical
history of respiratory disease and atopy; various re-
spiratory variables and laboratory findings of atopic
and infective markers, including expired nitric oxide
(NO) concentration, a recognized marker of allergic
inflammation8; and antigen and antibodies for chla-
mydia, a microorganism known to be associated
with asthma.9 We also assessed the reproducibility of
nasal cell counts and investigated whether local cor-
ticosteroid therapy would restore altered nasal cel-
lularity to normal.
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METHODS
Study Population
The study and the procedure had the approval of the ethics
committee of the Pediatric Clinic at the University of Rome, La
Sapienza. We studied an unselected population of children who
attended an elementary school in Ronciglione (Viterbo; age range:
9–11 years). The population was recruited by sending a letter to
parents of all children in classes IV and V. There were 203 eligible
children. The parents of 200 gave informed consent for their
children to participate. Before the study, 200 parents completed a
questionnaire seeking information on the history of atopic and
respiratory symptoms; information on questions and on derived
definitions of atopic and respiratory disease have been detailed
elsewhere.8 Mainly, they reproduce the definitions internationally
agreed on in the International Study of Asthma and Allergies in
Childhood.10
Only 183 of the children who were enrolled completed the
programmed procedures. The 17 children who were excluded
(because of absences or refusal to undergo important procedures)
did not differ as a group for history or available variables from the
cases that were finally included in the study. All children then
underwent a preliminary clinical examination, and those who had
acute respiratory symptoms were asked to return and entered the
study when their symptoms had cleared. All procedures where
accomplished within 45 days.
Nasal Swabs
Nasal cytology was studied in eluates from nasal swabs ob-
tained in the middle third of the inferior turbinate using sterile
swabs mounted on aluminum sticks. During the examination,
both nostrils were scraped with the same swab, which was sub-
sequently eluted in 3 mL of saline solution and transported within
6 hours to the laboratory at the Pediatric Clinic “Policlinico Um-
berto I,” Rome. Slides were prepared from cytospin preparations
and stained with May-Gru¨nwald-Giemsa for identification of
squamous epithelial cells, ciliated epithelial cells, lymphocytes,
eosinophils, and neutrophils on the basis of cell shape, size, and
nuclear configuration. White cells were counted with an optic
microscope (Leitz Aristoplan, Wetzlar, Germany), and the per-
centage of each white cell population was determined.11 Because
most samples contained no eosinophils and only a few had 1% or
fewer (2% in 2 samples), in all samples the percentage of eosino-
phils was assumed to be 0.
Nasal Cell Repeatability
Nasal cell percentages above the 66th percentile were defined
as elevated. To assess the repeatability of nasal cellularity 1 month
after the first measurement, we asked 20 children with elevated
neutrophil percentages (14%) in nasal swabs eluated and 11 with
neutrophil counts within the normal limits to repeat the nasal
swab; all of them agreed to undergo this procedure.
Effects of Local Steroid Therapy
To assess the effects of local corticosteroid therapy in restoring
altered nasal cellularity, we asked 16 children in whom we had
found increased nasal neutrophils on two occasions to undergo a
15-day trial of nasal flunisolide inhalation.
DNA Polymerase Chain Reaction for Chlamydia
pneumoniae
A total 100 L of nasal aspirates was proteinase K digested
(50 g/ml) for 1 hour at 55°C, phenol extracted, ethanol precipi-
tated, then resuspended in Tris-ethylenediaminetetraacetic acid.
Samples were assayed in a nested DNA polymerase chain reaction
(PCR) using specific primers selected from major outer membrane
protein.12 The outer (first round) primers used were APNOU
(5-AATTCTCTGTAAACAAACCC-3) and APNOL (5-ATTAA-
GAAGCTCTGAGCATA-3), and the inner (second round) prim-
ers were APN1 (5-AGCCTAACATGTACACTCTGAT-3) and
APN2 (5-TGCCAACAGACGCTGCGT-3) generating a 487-bp
product detected by gel electrophoresis.
PCR reaction buffers, AmpliTaq Gold DNA polymerase, and
oligonucleotide primers were provided by Perkin Elmer Applied
Biosystems (Foster City, CA). The final PCR mixture contained
10  PCR buffer II, 2 mmol/L MgCl2, 1 M of each primer, 0.8
mmol/L dNTPs, 1 U of AmpliTaq Gold, and 2 L of template.
After preincubation at 94°C for 5 minutes, the reaction cycle
consisted of denaturation at 94°C for 75 seconds and annealing at
52°C for 75 seconds for the first round or 63°C for 75 seconds for
the second round, and the extension at 72°C for 60 seconds, with
30 cycles for the first round and 35 cycles for the second round.
The sensitivity by second-round gel was 4.5 fg of C pneumoniae
DNA. A short (550 bp) cloned fragment of C pneumoniae genome
DNA and 2 clinical samples known to be positive for C pneumoniae
from a previous study13 were used for positive controls. Negative
controls were noninfected phosphate-buffered saline. All positive
samples were reconfirmed by repeat analysis, and all DNA ex-
tractions, primary PCR amplifications, and secondary PCR ampli-
fications were undertaken in distinct areas, using dedicated pi-
pettes and filtered tips.
Flow Volume Curves
A Cosmed Altair 1000 pneumotachograph (Cosmed Srl, Rome,
Italy) was used for spirometry. Forced expiratory volume in 1
second was selected from 3 repeatable maneuvers of forced vital
capacity, and results were expressed as a percentage of the pre-
dicted values.
Exhaled NO Measurements
Exhaled NO (eNO) was measured at the mouth as previously
described14 with a chemiluminescence NO analyzer (Sievers NOA
280, Boulder, CO; response-time: 0.02 seconds; sensitivity: 1 part
per billion [ppb], range of measures: 1–500 000 ppb, repeatabil-
ity:1 ppb; sampling flow: 200 mL/s). The 0 signal was calibrated
with an air filter (Sievers ACT 01400), and the measurement scale
was calibrated with a gas containing 10 parts per million NO in
nitrogen (SIAD Srl, Bergamo, Italy). Exhaled gas was collected into
1-L Mylar bags. Children exhaled through a calibrated needle
restrictor (internal diameter: 1.55 mm) keeping a constant pressure
of 10 cm H2O. All samples were transported to the laboratory and
analyzed with a maximum delay of 2 hours after collection; in
each child, eNO was calculated as the mean from 2 samples.
Nasal Volume
The equipment used for nasal volume measurements (Acoustic
Rhinometer EccoVision, SensorMedics, Yorba Linda, CA) con-
sisted of a pulse generator, a sound tube with a microphone
mounted in the wall and a nosepiece attached, a microphone
amplifier, and a computer for data analysis. A wave tube was
subsequently introduced into each nostril at an angle of 45° and
fitted tightly with a with a conical nosepiece. An audible sound
was propagated into nasal cavities. Local changes in acoustic
impedance were expressed as local changes in the cross-sectional
area. Two consecutive measurements were obtained in each nasal
cavity at the end of an oral blowing within approximately 1
second, and the maximum value was used for calculation.
TABLE 1. Cell Populations by Demographic Variables
Total
(100%)*
Boys
(44.8%)
Girls
(55.2%)
10 Years
(36.1%)
10 Years
(63.9%)
Neutrophils 15.0  17.4 15.6  18.6 14.5  16.5 17.0  18.1 13.8  17.0
Lymphocytes 1.5  3.8 1.2  3.1 1.7  4.3 1.0  3.3 1.7  4.1
Squamous epithelial cells 23.2  20.6 24.4  21.6 22.1  19.7 19.1  16.3 25.5  22.4
Ciliated epithelial cells 60.5  22.2 59.0  22.5 61.7  22.0 63.1  20.5 59.0  23.1
Values are mean  standard deviation.
* Percentage of the 183 studied children considered in the column.
1138 NASAL CELLULARITY IN UNSELECTED SCHOOLCHILDREN
 by on August 7, 2008 www.pediatrics.orgDownloaded from 
Blood Samples
Blood cytometric evaluation included a differential white cell
count and eosinophil percentages. Serum samples were stored in
aliquots at 70°C and subsequently tested for total immunoglob-
ulin (Ig) E by the immuno-CAP method (Pharmacia, Uppsala,
Sweden).
Microimmunofluorescence testing for IgG, IgA, and IgM anti-
bodies to purified C pneumoniae elementary bodies (strain 2023,
ATCC VR 1356) was done with a Chlamydia MIF Kit (Diamedix,
Miami, FL). The prevalence of C pneumoniae-specific IgG, IgA, and
IgM antibodies was based on the presence of IgA at the titers of
1:16 and IgG at the titers of 1:64.
Skin Prick Test
Allergen sensitization was measured by means of skin prick
tests in the volar aspect of the forearm by means of a previously
described technique.15 The battery of allergens comprised Der-
matophagoides pteronyssimus, cat hair, Aspergillus fumigatus, Alter-
naria tenuis, mixed grass, mixed tree pollen, Parietaria officinalis,
egg, and cow milk (Soluprick; ALK-Abello`, Horsholm, Denmark).
As positive and negative controls, we used histamine dihydro-
chloride (10 mg/mL) and diluent (50% glycerol and 50% physio-
logic saline). After 10 minutes, the wheal size was recorded in
millimeters as the long axis and its perpendicular; the mean of
these 2 measurements was calculated. A wheal 3 mm in size was
considered a positive skin reaction.
Statistical Analysis
Contingency tables (2 test) were used for comparison of pro-
portions. Cohen’s  with 95% confidence interval (CI) was calcu-
lated for measuring repeatability of nasal neutrophils. Reproduc-
ibility of 2 nasal volume measurements (intrasession) was
determined by the “coefficient of repeatability,” ie, 2 standard
deviations, which is the measure interval including 95% of the
differences between couples of measures.16 The Student t test for
independent samples was used to compare the changes in neu-
trophil counts and nasal volumes after the therapeutic cycle. All
data were computed with the software program SPSS (SPSS, Inc,
Chicago, IL). P  .05 was considered statistically significant.
RESULTS
Epidemiologic Results
The mean value of nasal volume was 4.16  0.94
cm3; the mean difference between duplicate intrases-
sion measurements was 0.006  0.369 cm3, with a
coefficient of repeatability of 0.738 cm3.
Readings of the cytospin preparations from nasal
swab eluates in 183 children disclosed the percent-
ages of cell populations reported in Table 1. No
significant difference in percentages for any white
Fig 1. Repeatability of percentage nasal neutrophil counts in 2 measurements obtained 1 month apart in 31 children. Dotted line
represents the 66th percentile (14%); Cohen’s : 0.535; 95% CI: 0.233–0.837; P  .002.
TABLE 2. Cell Populations by Clinical History
Normal Subjects*
(37.1%)
Chronic Rhinitis†
(15.1%)
Chronic Cough‡
(14.5%)
Previous Asthma
Diagnosis
(15.1%)
Previous Eczema
Diagnosis
(15.1%)
Neutrophils 12.9  13.3 12.4  16.2 12.2  14.5 16.1  15.5 19.5  22.8
(80th percentile: 22%)
(66th percentile: 14%)
Lymphocytes 1.9  4.2 1.2  2.3 0.46  1.2 1.9  3.5 2.24  5.31
(80th percentile: 2%)
(66th percentile: 0%)
Squamous epithelial cells 24.2 18.7 23.4  25.5 20.0  13.3 16.2  18.9 25.5  28.4
(80th percentile: 39%)
(66th percentile: 24%)
Ciliated epithelial cells 61.0 20.2 62.9  25.1 67.3  15.9 66.5  22.4 52.6  25.3
(80th percentile: 77%)
(66th percentile: 67%)
Values are mean  standard deviation.
* No chronic rhinitis, no chronic cough, no asthma, no eczema, no positive prick tests.
† Blocked or runny nose on most days of the previous 12 months.
‡ Cough on most days of the previous 12 months.
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cell population was found according to demographic
subdivisions (boy versus girl, age 9 vs 10–11 years;
Table 1). The repeat examination after 1 month in 31
children, 11 with normal neutrophil percentages
(14%) and 20 with elevated values (14%), overall
disclosed no significant variations in the percentages
of any white cell populations (Fig 1). In particular, in
the group of 20 children who originally had high
neutrophil percentages, 15 (75%) still had high val-
ues, whereas in the group of 11 children who origi-
nally had lower values, 9 (81.8%) had percentages
that remained low. Overall, the examination yielded
a reproducible result for neutrophil percentages in 24
of 31 children (77.4%; Cohen’s : 0.535; 95% CI:
0.233–0.837; P  .002). Percentages of nasal cell pop-
ulations were not significantly different according to
the questionnaire-derived clinical history (Table 2).
Similarly, children with laboratory findings outside
the normal range (including elevated atopic vari-
ables, reduced nasal volumes, or abnormal respira-
tory function variables, evidence of current or previ-
ous chlamydia nasal infection) and those with
laboratory findings within the normal range had
similar cell populations (Table 3).
Effect of Nasal Nebulization With Corticosteroids
The parents of 16 children in whom the second
measurement of nasal cytology had demonstrated
elevated neutrophilia were contacted by a physician
of our team and their children were invited to com-
plete a 15-day course of flunisolide nasal nebuliza-
tion, in agreement with the family physician. There
were 2 refusals. Of the remaining 14 children, 2 failed
to comply fully with the instructions for the pro-
grammed course of therapy (200 g twice daily for
15 days) and were excluded from further analysis.
Studies of nasal cytology and measurements of nasal
volume before and after therapy showed that both
variables improved significantly after flunisolide
(Figs 2 and 3).
DISCUSSION
We determined nasal cytology in a sample of un-
selected children who were aged 9 to 11 years. Nei-
ther any cell population nor the neutrophils—con-
sidered the expression of nasal inflammation17,18—
correlated with age, gender, history of nasal and
lower respiratory tract symptoms, or atopic history.
Several laboratory findings, including atopic and re-
spiratory variables, also showed no correlation with
nasal cytology. Nevertheless, when we repeated na-
sal cytology measurement 4 weeks later, the finding
remained remarkably stable: approximately 80% of
the children with increased or normal nasal neutro-
phils showed a persistent finding at the second mea-
surement. This result induced us to suggest that the
small group of the children who had persistent nasal
neutrophilia should undergo a 15-day therapeutic
trial with corticosteroids. Flunisolide therapy sub-
stantially reduced nasal neutrophils and increased
nasal volume.
Our results therefore suggest that nasal neutro-
philia, of intensity higher than 14% (66th percentile
in our population), although unrelated to demo-TA
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graphic, respiratory, or atopic indices, tends to per-
sist if untreated and is significantly reduced by cor-
ticosteroid treatment. Nasal neutrophilia (at a the
rate found in 33% of an unselected child population)
represents a persistent inflammatory state that can be
relieved only by a therapeutic intervention. How-
ever, because corticosteroid therapy decreased the
neutrophil count and in parallel increased the vol-
ume of the nasal cavities, the inflammation presum-
ably has cellular as well as clinical importance.
In evaluating the importance of this local inflam-
mation, it is relevant to remember that we conducted
our initial examination only in children without
acute symptoms and in a period of the year (Novem-
ber–January) when in our geographic setting sea-
sonal allergic stimulation from pollen is unlikely and
that from D pteronyssimus is not at its maximum.
Nasal neutrophils (together with eosinophils and ba-
sophils) are known to increase in subjects with pollen
sensitization after specific nasal challenge both in
immediate and in late-phase reactions.18–20 In nonal-
lergic subjects, a challenge with irrelevant allergens
or with pure diluent causes a significant increase in
neutrophils but leaves eosinophils and basophils un-
changed.2
Even if the role of neutrophils in nasal eluates
Fig 2. Neutrophil percentages in the 12 children who had14% neutrophils in nasal white cell counts on 2 occasions and who underwent
local nasal therapy with flunisolide.
Fig 3. Nasal volumes in the 12 children who had 14% neutrophils in nasal white cell counts on 2 occasions and who underwent local
nasal therapy with flunisolide.
ARTICLES 1141
 by on August 7, 2008 www.pediatrics.orgDownloaded from 
remains unclear, these cells seem to play a nonspe-
cific role and to represent a reaction of the nasal
mucosa after any kind of stimulus.2 That our study
population included a subgroup of children in whom
neutrophils were persistently high suggests that ei-
ther these children live in environments abnormally
rich in irritative stimuli or that they have unusual
nasal reactivity to normal environment stimulation
(or a variable combination of these 2 components).
Numerous observations show that neutrophil ac-
tivity characterizes several forms of acute or chronic
nasal inflammation.21,22 Neutrophil activity is influ-
enced by several mediators that enhance their migra-
tion, adhesion, and degranulation.17 Neutrophils can
also be activated by their exposure to substances (eg,
platelet adherence factor, leukotrienes, and cyto-
kines) that enhance the effects of other agonists
(priming effect).23,24 The number of neutrophils in
the nasal fluid of schoolchildren with allergic rhinitis
correlate to the levels of interleukin-8.25 The most
intriguing finding of our investigation is that this
neutrophilic nasal inflammation, present in a large
proportion of our unselected population, is in no
way predicted by or associated with the variables
normally used for the clinical assessment of children.
Atopy is considered one of the most important
cause of nasal symptoms in childhood: the incidence
of allergic rhinitis has substantially increased in the
past 30 years. In our population, however, we found
no relationship of nasal cytology with the results of
prick tests or total serum IgE or blood eosinophils or
with a history of chronic rhinitis, asthma, eczema, or
chronic cough.
Respiratory function tests such as spirometry and
eNO concentrations also failed to predict neutro-
philic nasal inflammation. This finding suggests that
nasal inflammation could be a strictly local phenom-
enon and that the concept of “one airway, one dis-
ease” supported by the frequent association at the
epidemiologic level between asthmatic and rhinitic
symptoms has some exceptions at least at the cellular
level.26,27 The evidence of a nasal infection with C
pneumoniae, a microorganism strongly associated
with respiratory illness,9,28 also did not predict nasal
neutrophilia.
CONCLUSION
The findings of this study suggest that no other
investigation can substitute a study of nasal cellular-
ity. Nonetheless, the practical meaning of altered
nasal cellularity and the threshold of severity for
therapeutic intervention needs to be clarified better
by means of additional studies, including measure-
ments of nasal cytokines in association with nasal
neutrophils. However, this simple, noninvasive ex-
amination can already help to guide the clinician in
assessing patient compliance and the effectiveness of
nasal corticosteroid inhalation therapy.
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